Recent News

ASTRO 2022: Long-Term Outcomes With a Three-Fraction Partial-Breast Irradiation Strategy

EBCC 2022: Are Changes in Blood Proteins an Early Signal of Breast Cancer?

SITC 2022: Neoantigen-Specific Antibody Responses in Metastatic Triple-Negative Breast Cancer

EBCC 2022: Risk Prediction Model and Individualizing Breast Cancer Screening Strategies

SITC 2022: Neoadjuvant Combination of Radiotherapy and Pembrolizumab in Triple-Negative Breast Cancer

ASTRO 2022: Can Regional Node Irradiation Reduce Risk for Locoregional Breast Cancer Recurrence?

ASTRO 2022: Phase III Trial Compares 3 Versus 6 Weeks of Radiation Therapy for Early-Stage Breast Cancer

Dose-Dense Adjuvant Chemotherapy in Early-Stage Breast Cancer: 15-Year Italian Trial Update

Identifying Genomic Characteristics of Breast Cancers Linked to PTEN Hamartoma Tumor Syndrome

ASTRO 2022: Radiation Dose and Long-Term Lymphedema Risk in Patients With Breast Cancer

ASTRO 2022: Final Study Results With Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer

Can a Silicone-Based Polyurethane Film Dressing Prevent Acute Radiation Dermatitis in Breast Cancer?

Darolutamide for AR-Positive, Advanced Triple-Negative Breast Cancer: Phase II Study Results

Adding Palbociclib to Standard Adjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer

Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer: 20-Year Trial Update

Can Hand Cooling and Compression Prevent Nerve Pain in Patients With Breast Cancer?

Neoadjuvant Endocrine Therapy for Breast Cancer: Differential Responses in Black Versus White Women

Phase III DAWNA-2 Trial: Dalpiciclib Plus Endocrine Therapy for Advanced Breast Cancer

FDA Brief: Priority Review for Sacituzumab Govitecan in HR-Positive, HER2-Negative Metastatic Breast Cancer

ASCO Quality 2022: Causes of Variation in Receipt of Axillary Surgery in Older Patients With Breast Cancer

Blocking CD73 With Oleclumab in Combination Therapy for Triple-Negative Breast Cancer

ASCO Quality 2022: Survey Identifies Knowledge Gaps in Breast Cancer Screening Practices for Transgender People

Patterns of Genomic Instability and Resistance to Endocrine Therapy in Metastatic Breast Cancer

ESMO 2022: Biomarker Analyses Focus on Resistance to T-DXd in Metastatic Breast Cancer

Oral Versus Intravenous Paclitaxel Treatment in Metastatic Breast Cancer

ESMO 2022: Overall Survival Data From MonarcHER Support Abemaciclib-Based Therapy for Advanced Breast Cancer

ESMO 2022: Patient-Reported Outcomes From DESTINY-Breast04 in Metastatic Breast Cancer

ESMO 2022: MONARCH 3 Survival Update on Abemaciclib-Based Therapy for Advanced Breast Cancer

ESMO 2022: Overall Survival Update From TROPiCS-02 Trial of Sacituzumab Govitecan in Metastatic Breast Cancer

FDA Safety Alert: Skin Cancer and Various Lymphomas in Scar Tissue Around Breast Implants

ESMO 2022: METEORA-II Trial Evaluates Triplet Regimen in Advanced Breast Cancer

ESMO 2022: Chemotherapy Plus Immunotherapy for Estrogen Receptor–Positive Metastatic Breast Cancer

Metastatic Breast Cancer: Does Collagen Play a Role in the Microenvironment?

Does Neurotoxic Chemotherapy Induce Hearing Problems in Cancer Survivors?

Using Nanomedicine to Target Tumors and Lymph Nodes in Triple-Negative Breast Cancer

Are Breast Cancer Survivors Adequately Informed About Sexual Health Effects? Study Says Maybe Not

MRI After Silicone Implant Breast Surgery: How Many Women Are Really Being Screened?

Development of an Asian Population–Specific BRCA Mutation Prediction Model

Supine Versus Prone Breast Radiotherapy: Impact on the Skin of Women With Large Breasts

FDA Grants Priority Review to Elacestrant in Advanced Breast Cancer

Can Ceritinib Combination Therapy Reduce the Growth of Triple-Negative Breast Cancer?

T-DXd: First Targeted Therapy for HER2-Low Breast Cancer Approved by the FDA

Plant-Based Diets and Risk of Developing Breast Cancer in Older Women

New Metric May Help to Predict Long-Term Survival in Triple-Negative Breast Cancer

T-DXd Granted Priority Review by the FDA in HER2-Low Metastatic Breast Cancer

Is the Risk of Breast Cancer in Men Influenced by Infertility?

Updated ASCO Guideline for the Use of Biomarkers in Early-Stage Breast Cancer

Ancestry-Specific Risks of Triple-Negative Breast Cancer and Genetic Mutations

FDA Brief: Biologics License Application Accepted for Trastuzumab Duocarmazine in Advanced Breast Cancer

Does a Live Birth After Treatment for Breast Cancer Affect a Woman’s Survival?

FAKTION Trial: Mature Survival Data on Use of Fulvestrant Plus Capivasertib in Metastatic Breast Cancer

Impact of Diet and Exercise on Chemotherapy Completion in Patients With Breast Cancer

Reanalysis of BIG 1-98, SOFT, and TEXT Trials: Focus on Clinical High-Risk Subgroups

Novel Genomic Test May Predict Response to Dose-Dense Chemotherapy in Breast Cancer

ASCO 2022: Adjuvant Endocrine Therapy Plus Chemotherapy in Older Women With Breast Cancer

ASCO 2022: Long-Term Benefits of Denosumab Reported in Hormone Receptor–Positive Breast Cancer

Study Identifies Genetic Locus Potentially Linked to Treatment Response in Breast Cancer

ASCO 2022: Updated Safety Data From DESTINY-Breast03 on T-DXd Versus T-DM1 in Metastatic Breast Cancer

Do Diabetes and Glycemic Control Impact Outcomes in Patients With Metastatic Breast Cancer?

ASCO 2022: Endocrine Therapy Plus Ribociclib for CDK4/6 Inhibitor–Resistant Metastatic Breast Cancer

ASCO 2022: Novel HER3-Directed Antibody-Drug Conjugate Under Study in Metastatic Breast Cancer

ASCO 2022: Survival Update From PALOMA-2 With Palbociclib Plus Letrozole in Advanced Breast Cancer

ASCO 2022: Can Some Older Women With Breast Cancer Avoid Radiotherapy After Breast-Conserving Surgery?

ASCO 2022: DESTINY-Breast04 Reports Benefit of T-DXd in HER2-Low Metastatic Breast Cancer

ASCO 2022: TROPiCS-02 Meets Study Endpoint With Sacituzumab Govitecan-hziy in Advanced Breast Cancer

CDK Inhibition Plus Endocrine Therapy for Breast Cancer: Case Presentations

Novel Imaging Agent Under Study in Breast-Conserving Surgery: Focus on Intraoperative Margins